[1] VARGAS M,HORCAJADA J P,OBACH V,et al.Clinical consequences of infection in patients with acute stroke:Is it prime time for further antibiotic trials?[J] Stroke,2006,37:461-465.
[2] HOWARD R J,SIMMONS R L. Acquired immunologic deficiencies after trauma and surgical procedures[J].Surg Gynecol Obstet,1974,139:771-782.
[3] PRASS K,MEISEL C,HFLICH C,et al.Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation[J].Exp Med,2003,198:725-736.
[4] VOGELGESANG A,GRUNWALD U,LANGNER S,et a1.Analysis of lymphocyte subsets in patients with stroke and their influence on infection after stroke[J].Stroke,2008,39:237-241.
[5] KLEHMET J,HARMS H,RICHTER M,et al.Stroke-induced immunodepression and post-stroke infections:lessons from the preventive antibacterial therapy in stroke trial[J].Neuroscience,2009,158(3):1184-1193.
[6] 张金华,闫福岭.脑梗死大鼠外周血促炎/抗炎细胞因子的动态变化[J].中华脑血管病杂志:电子版,2010,4(2):88-94.
[7] OFFNER H,SUBRAMANIAN S,PARKER S M,et a1.Experimental stroke induces massive,rapid activation of the peripheral immune system[J].Cereb Blood Flow Metab,2006,26:654-665.
[8] KNUTSEN A P,FREEMAN J J,MUELLER K R,et al.Thymosin1alphal stimulates maturation of CD34+stem cells into CD3+4+cell in an in vitro thymic epithelia organ coculture model[J].Int J Immuopharmacol,1999,21(1):15-26.
[9] SILECCHIA G,GUARINO E,SINIBALDI-VALLEBONA P.Efficacy of repeated cycles of chemo-immunotherapy with thymosin alpha1 and interleukin-2 after intraperitoneal 5-fluorouracil delivery[J].Cancer Immunol Immuother,1999,48(4),172-178.
[10] 钟国成,郭宁.增强树突状细胞抗原呈递功能的新进展[J].细胞与分子免疫学杂志,2004,20(2):253-256.
[11] 杨平满,周建英,程正文,等.胸腺肽α1 联合抗菌药物治疗老年耐药铜绿假单胞菌性肺炎疗效观察[J].中华医院感染学杂志,2011,21(13):2792-2794.
[12] 朱红俊,徐俊龙,刘宏.胸腺肽辅助治疗老年重症肺炎时的细胞免疫功能观察[J].现代中西医结合杂志,2006,15(5):599-600.
[13] 彭乐,黄小疆,杜宁.胸腺肽-α1 对预防老年医院获得性肺炎及免疫功能的影响[J].临床和实验医学杂志,2006,5(10):2550-2551.
[14] 李轶炜,王瑞萍,王煜.胸腺肽α1 对老年2 型糖尿病重症肺炎患者的疗效及细胞免疫功能的影响[J].中国社区医师,2010,12(31):163.
[15] 王志海,陈颖.胸腺肽α1对脑梗死患者院内获得性肺炎的预防作用[J].海南医学院学报,2011,17(7):253.
[16] EMSLEY H C,SMITH C J,TYRRELL P J,et a1.Inflammation in acute ischemic stroke and its relevance to stroke critical care[J].Neurocrit Care,2008,9:125-138.
[17] BECKER K J,Mc CARRON R M,RUELZLCR C,et a1.Immunologic tolerance to myelin basic protein decreases stroke size after transient focal cerebral ischemia[J].Proc Natl Acad Sci USA 1997,94:10873-10878.
[18] DIMITRIJEVIC O B,STAMATOVIC S M,KEEP R F,et a1.Absence of the chemokine receptor CCR2 protects against cerebral ischemia/reperfusion injury in mice[J].Stroke,2007,38:1345-1353.
[19] HUM P D,SUBRAMANIAN S,PARKER S M,et a1.T-and B-cell-deficient mice with experimental stroke have reduced lesion size and inflammation[J].Cereb Blood Flow Metab,2007,27:1798-1805.
[20] FIGIEL I.Pro-inflammatory cytokine TNF-α as a neuroprotective agent in the brain[J].Acta Neurobiol Exp (Wars),2008,68:526-534.
[21] CLARK W M,RINKER L G,LESSOV N S,et a1.Lack of imerleuldn-6 expression is not protective against focal central nervous system ischemia[J].Stroke,2000,31:1715-1720.
[22] EMSLEY H C,SMITH C J,GEORGIOU R F,et a1.A randomized phase Ⅱ study of interleukin-1 receptor antagonist in acute stroke patients[J].Neurol Neurosurg Psychiatry,2005,76:1366-1372.
[23] MEISEI C,PRASS K,BRAUN J,et a1.Preventive antibacterial treatment improves the general medical and neurological outcome in a mouse model of stroke[J].Stroke,2004,35:2-6.
[24] CHAMORRO A,HORCAJADA J P,OBACH V,et a1.The early systemic prophylaxis of infection after stroke study:a randomized clinical trial[J].Stroke,2005,36:1495-1500.
[25] 李佳,刘玲,杨毅.ICU鲍氏不动杆菌肺炎的预后和危险因素分析[J].现代医学,2010,38(1):6-10. |
